Primary Site >> Liver Cancer

Gene >> PDZD2

  • 2006
  • 2007
  • 2009
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Interaction of Pin1 with Nek6 and characterization of their expression correlation in Chinese hepatocellular carcinoma patients.
PMID: 16476580
Ref: Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
PMID: 17383430
Ref: Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses".
PMID: 17383439
Ref: The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
PMID: 19168580
Ref: Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells.
PMID: 25742740
Ref: Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
PMID: 26133706
Ref: Prolyl isomerase Pin1 regulates cadmium-induced autophagy via ubiquitin-mediated post-translational stabilization of phospho-Ser GSK3alphabeta in human hepatocellular carcinoma cells.
PMID: 26445356
Ref: Pin1 facilitates NF-kappaB activation and promotes tumour progression in human hepatocellular carcinoma.
PMID: 26461058
Ref: Understanding the role of PIN1 in hepatocellular carcinoma.
PMID: 28018099
Ref: miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.
PMID: 28076852
Ref: Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways.
PMID: 28262728
Ref: MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.
PMID: 28383568
Ref: Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
PMID: 28404959
Ref: Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.
PMID: 29225033
Ref: A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.
PMID: 29170140
Ref: Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.
PMID: 29381806
Ref: Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma.
PMID: 29445125
Ref: Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells.
PMID: 30093655